SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-149353
Filing Date
2023-05-19
Accepted
2023-05-19 16:21:06
Documents
13
Period of Report
2023-05-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d469753d8k.htm   iXBRL 8-K 37073
  Complete submission text file 0001193125-23-149353.txt   202877

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mgta-20230515.xsd EX-101.SCH 3884
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgta-20230515_def.xml EX-101.DEF 14084
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20230515_lab.xml EX-101.LAB 23366
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20230515_pre.xml EX-101.PRE 15117
7 EXTRACTED XBRL INSTANCE DOCUMENT d469753d8k_htm.xml XML 5199
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38541 | Film No.: 23940405
SIC: 2834 Pharmaceutical Preparations